The global particle therapy devices market (mainly proton therapy devices) reached just below US$ 0.8 billion in 2015. Market growth has accelerated during the last five years, showing an average annual growth rate of 19% from 2010 to 2015. For the first time, the proton therapy world market is anticipated to reach over US$ 1 billion in 2018, one year sooner than previously estimated. It is projected to reach between US$ 3.5 and 6.6 billion by 2030, with 1,200 to 1,800 particle therapy treatment rooms open to patients worldwide. However, in 2015 only 0.5% of the population that needs access to external radiotherapy was treated with proton therapy. Even with 1,800 treatment rooms in 2030, this will allow only 12% of this population to be able to receive proton therapy treatment. As the market emerges and becomes a real part of the global radiotherapy world, most proton therapy vendors already have, or are developing a compact PT system. Also, several newcomers have recently started the development of proton therapy equipment and should enter the market in the coming years. In addition to proton therapy, there is also an increasing interest toward carbon therapy with the emergence of several projects in a few countries as well as new and existing firms willing to enter this market segment. A comprehensive review of the Proton Therapy World Market is available from MEDraysintell, providing in a 290-page document a complete review of the world market dynamics. It analyzes both past evolutions and future trends to the year 2030, and contains a detailed profile of 26 promoters, manufacturers or developers of proton and carbon therapy equipment.

1. MEDraysintell
EDITION2016
© 2016
www.medraysintell.comA report written by Paul-Emmanuel Goethals & Richard Zimmermann
PROTON
THERAPY
WORLD MARKET REPORT & DIRECTORY

2. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Proton Therapy,Edition 2016
 Proton Therapy remains a niche market, representing just
over 1% of all the external radiotherapy systems installed
worldwide
 In 2015, only 0.5% of the population that requires an
external radiotherapy was treated with proton therapy

3. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Proton Therapy,Edition 2016
 The Proton Therapy market represents 0.01% of the global
health expenditures but should grow three times faster
 Global Health market: US$ 7,300 billion (2015), growth 3-4% a year
 PT market: US$ 0.8 billion (2015), growth 11% annually

4. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Proton Therapy,Edition 2016
 The global Proton Therapy market is projected to reach
between US$ 3.5 to 6.6 billion by 2030, with 1,200 to 1,800
particle therapy treatment rooms open to patients
worldwide, showing an annual growth of 11% to 16%
 Even with 1,800 treatment rooms in 2030, this will allow only 12%
of the population that needs access to external radiotherapy to be
able to receive proton therapy treatment

5. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Proton Therapy,Edition 2016
 For the first time, the proton therapy world market is
anticipated to reach over US$ 1 billion in 2018

6. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Proton Therapy,Edition 2016
 Less than 20 companies are active in the global proton
therapy market, several already selling a PT system and
some newcomers with a proton therapy equipment under
development and an expected market entry in the coming
years. Three dominant vendors share 45% of the market

7. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Proton Therapy
Published in October 2016 (4th Edition)
 A 290-page document analyzing both past
evolutions and future trends to the year 2030,
and contains a detailed profile of 26 promoters,
manufacturers or developers of proton and
carbon therapy equipment
A detailed table of contents and sample pages are
available upon request, please send an e-mail with
your contact details to: peg@medraysintell.com

8. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
About MEDraysintell
4th
Edition
More than 40 years of experience in
 Nuclear Medicine
 Particle therapy
 Brachytherapy
MEDraysintell provides strategic intelligence
for the radiation healthcare to help clients
understand
 Markets
 Competitive environment
 Potential for M&A
 Technology development
The most comprehensive set of reports &
directories with over 1,900 pages of unrivaled
intelligence, covering some of the most
exciting healthcare technologies using
radiation for diagnosis and treatment.
3rd
Edition
2nd
Edition
1st
Edition

9. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Contact
Paul-Emmanuel Goethals, MBA
Louvain-la-Neuve, Belgium
peg@medraysintell.com
Phone: +32 491 080 968
Copyright © 2016, MEDraysintell (CSIntell and Chrysalium Consulting), All rights reserved.
 MEDraysintell reports and directories can be customized to
specific areas or modalities
 Sample pages and complete table of contents are available
upon request
 MEDraysintell also welcomes your requests for specific
intelligence needs
Dr. Richard Zimmermann, PhD
Lalaye, France
rz@medraysintell.com
Phone: +33 6 82 80 06 00

10. Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors! © MEDraysintell 2016
Disclaimer
This MEDraysintell presentation and information contained herein, coming from the report “Proton Therapy World
Market Report & Directory, Edition 2016” is believed to be accurate at the time of publication; it has been gathered in
good faith from several sources, but the authors are not in a position to guarantee its accuracy. The authors do not
accept any responsibility for the content of this report. Information contained herein may be of a speculative nature
and must be used with careful consideration. The authors assume no liability for any loss or damage – including but
not limited to lost time, lost money, lost profits, lost customers – that may result from any use of the information or
actions taken based on any analyses, projections, discussions, recommendations, or conclusions of any kind
presented in this report.